Section A: Submissions for registration
The committee provided advice on two submissions:
- Extension of indication for Gardasil 9 by provisional registration (product name Human papillomavirus 9-valent vaccine, recombinant; sponsor Merck Sharp & Dohme (Australia) Pty Ltd).
- New vaccine for pre-exposure and post-exposure prophylaxis against rabies (product name Rabies virus vaccine inactivated; brandname Verorab; sponsor Sanofi).
Details of the ACV advice associated with these premarket items has been or will be released within the Australian Public Assessment Report (AusPAR). To browse all AusPARs see AusPAR search.
Section B: Safety
The committee was not asked to provide advice on any safety matter.
Further information
For further information on the ACV, please visit Advisory Committee on Vaccines or contact the ACV by email ACV@health.gov.au.